HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

[Influence of cholesterol on macrophage foam cells formation at zymosan-induced inflammation of mice].

Abstract
It has been shown recently that significant number (to 40% from total population) of macrophage foam cells (MFC) is formed during early time (24 h) of zymosan-induced peritonitis resolution and agonists of peroxisome proliferation activated receptors-α, -γ (PPAR-α, -γ) exert anti-inflammatory action, protecting their formation (Dushkin et al., 2007). The work is devoted to investigate of the influence of cholesterol-containing liposomes (CHL) on dinamic of zimozan-induced peritonitis in C57Bl/6 mice. The accumulation of cholesterol, the change of cytokine production, PPAR-γ activity and cholesterol efflux in macrophages of C57Bl/6 mice has been investigated. The infiltration of neutrophils, amounts of mononuclear cells and MFC formation were significantly increased in peritonel cavity of zymosan-induced mice that led to in expansion of the period of inflammatory resolution and of the period of MFC resolution. If macrophages obtained after zymosan injection mainly accumulated triglycerides (TG) and at high speed incorporated [1-14C]oleate into TG, the injection of CHL after zymosan-indused inflammation lead to dramatic promotion MFC containing primarily free cholesterol and Ch ethers and been aggravation of [1-14C]oleate incorporation into cholesterol ethers in macrophages (mainly for 2 days). It has to shown that CHL against a background of inflammation promoted reduction of fluorescent NBD-cholesterol efflux from macrophages throughout the studied period (5 days) whereas zymosan inhibited cholesterol efflux at the early stages of inflammation (1 and 2 days), then, on 3ed day, the cholesterol efflux was recovered and increased on day 5. At the same time CHL stimulated the production of TNFα and TGFβ and inhibited the production of IL-10 and DNA-binding activity of PPAR-γ macrophages obtained at early as well as late stages of zymosan-induced peritonitis (compared with injection zymosan only). Thus, accumulation of cholesterol in inflammatory macrophages and promotion of MFC formation prolog timely resoluti- on of acute inflammation inducing alteration of pro- and anti-inflammatory cytokine balance and evoking the repression of macrophage DNA-binding activity of PPAR-γ and cholesterol efflux.
AuthorsO M Dolganova, M I Rudina, M V Khrapova, M I Dushkin
JournalTsitologiia (Tsitologiia) Vol. 56 Issue 2 Pg. 132-41 ( 2014) ISSN: 0041-3771 [Print] Russia (Federation)
PMID25509153 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
Chemical References
  • 7-nitrobenz-2-oxa-1,3-diazol-4-ylcholesterol
  • IL10 protein, mouse
  • Liposomes
  • PPAR gamma
  • Transforming Growth Factor beta
  • Triglycerides
  • Tumor Necrosis Factor-alpha
  • Interleukin-10
  • Oleic Acid
  • Zymosan
  • Cholesterol
  • 4-Chloro-7-nitrobenzofurazan
Topics
  • 4-Chloro-7-nitrobenzofurazan (analogs & derivatives, metabolism)
  • Animals
  • Biological Transport
  • Cholesterol (analogs & derivatives, metabolism, pharmacology)
  • Foam Cells (drug effects, metabolism, pathology)
  • Inflammation (chemically induced, metabolism, pathology)
  • Interleukin-10 (biosynthesis, metabolism)
  • Liposomes (chemistry, pharmacology)
  • Male
  • Mice
  • Mice, Inbred C57BL
  • Neutrophil Infiltration (drug effects)
  • Neutrophils (drug effects, metabolism, pathology)
  • Oleic Acid (metabolism)
  • PPAR gamma (antagonists & inhibitors, metabolism)
  • Peritonitis (chemically induced, metabolism, pathology)
  • Transforming Growth Factor beta (biosynthesis, metabolism)
  • Triglycerides (metabolism)
  • Tumor Necrosis Factor-alpha (biosynthesis, metabolism)
  • Zymosan

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: